ArticleBlood advances2022

t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity.

Sarah B Mueller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.